Allogeneic Stem Cell Transplantation for Adults with Myelodysplastic Syndromes: Importance of Pretransplant Disease Burden

Medicine & Life Sciences

• Myelodysplastic Syndromes 100%
• Allogeneic Cells 95%
• Stem Cell Transplantation 92%
• Confidence Intervals 52%
• Disease-Free Survival 38%
• Recurrence 31%
• Transplants 21%
• Fetal Blood 20%
• Bone Marrow 19%
• Refractory Anemia with Excess of Blasts 19%
• Peripheral Blood Stem Cells 17%
• Unrelated Donors 17%
• Hematopoietic Stem Cell Transplantation 14%
• Mortality 13%
• Incidence 13%
• Myelodysplastic-Myeloproliferative Diseases 12%
• Tissue Donors 10%
• Leukemia, Myelomonocytic, Chronic 9%
• Refractory Anemia 9%
• Whole-Body Irradiation 8%
• Survival 7%
• Graft vs Host Disease 7%
• Therapeutics 6%
• Neutrophils 5%
• Transplantation 5%